The drugs of the LPG-1 family, including semaglutide — the active principle of Ozempic— could open a new front in the treatment of addictions. Drugs originally designed to control type 2 diabetes and which subsequently revolutionized the pharmacological management of obesity are now being investigated for a possible third effect: [...] The Ozempic entry opens a new way to treat alcohol addictions and other drugs was first published in The Journa…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The drugs of the LPG-1 family, including semaglutide — the active principle of Ozempic— could open a new front in the treatment of addictions. Drugs originally designed to control type 2 diabetes and which subsequently revolutionized the pharmacological management of obesity are now being investigated for a possible third effect: [...] The Ozempic entry opens a new way to treat alcohol addictions and other drugs was first published in The Journa…